Warren symposium follows legacy of geneticist giant

If we want to understand how the brain creates memories, and how genetic disorders distort the brain’s machinery, then the fragile X gene is an ideal place to start. That’s why the Stephen T. Warren Memorial Symposium, taking place November 28-29 at Emory, will be a significant event for those interested in neuroscience and genetics. Stephen T. Warren, 1953-2021 Warren, the founding chair of Emory’s Department of Human Genetics, led an international team that discovered Read more

Mutations in V-ATPase proton pump implicated in epilepsy syndrome

Why and how disrupting V-ATPase function leads to epilepsy, researchers are just starting to figure Read more

Tracing the start of COVID-19 in GA

At a time when COVID-19 appears to be receding in much of Georgia, it’s worth revisiting the start of the pandemic in early 2020. Emory virologist Anne Piantadosi and colleagues have a paper in Viral Evolution on the earliest SARS-CoV-2 genetic sequences detected in Georgia. Analyzing relationships between those virus sequences and samples from other states and countries can give us an idea about where the first COVID-19 infections in Georgia came from. We can draw Read more

Uncategorized

Emory Cardiologist Helps Rank Top Diets

Laurence Sperling, MD

It’s a new year and shedding pounds is at the top of the resolution list for many Americans. To help dieters lose weight and jump start healthier eating habits, Emory Heart & Vascular Center cardiologist Laurence Sperling, MD served on a U.S. News & World Report panel evaluating some of the country’s most popular diets.

The rankings, released today, include U.S. News’ second annual list of Best Diets, featuring its first-ever ranking of Easiest Diets to Follow. It includes six other rankings first assessed and published in 2011: Best Diets Overall, Best Commercial Diet Plans, Best Weight-Loss Diets, Best Diets for Healthy Eating, Best Diabetes Diets, and Best Heart-Healthy Diets.

According to U.S. News, dieters who choose a diet at or near the top of the new Easiest Diets to Follow list are more likely to succeed in staying on their diet for the long haul. Weight Watchers took the top spot on that list, followed by Jenny Craig, the Mediterranean Diet, Slim-Fast and Volumetrics.

The five new diets added for 2012 are the Abs Diet, Biggest Loser Diet, Dukan Diet, Flat Belly Diet, and Macrobiotic Diet.

Big winners across the rankings included:

  • DASH Diet: ranked #1 in Best Diets Overall, Best Diets for Healthy Eating, and Best Diabetes Diets (tie)
  • Weight Watchers: ranked #1 in Best Weight-Loss Diets, Best Commercial Diet Plans, and Easiest Diets to Follow
  • Biggest Loser Diet: ranked #1 in Best Diabetes Diets (tie)
  • Ornish Diet: ranked #1 in Best Heart-Healthy Diets

To create the rankings, U.S. News turned to Sperling and the same 22 experts for Best Diets 2012 as it did for Best Diets 2011. The panel, which included nutritionists, dietitians, cardiologists and diabetologists, reviewed 25 popular diet profiles that were developed by reporters and editors at U.S. News.

“I can’t say enough about their commitment and hard work,” said Avery Comarow, U.S. News Health Rankings Editor. “They enabled us to provide meaningful, evidence-based rankings.”

Sperling is a professor of medicine at Emory University School of Medicine and director of Emory’s Center for Heart Disease Prevention.

For a complete list of the new diet rankings, please visit:

http://health.usnews.com/best-diet

 

Posted on by admin in Uncategorized 2 Comments

Caution on cardiovascular cell therapies

The technique of using someone’s own bone marrow cells to treat disease may present risks of promoting tumor development, according to a recent paper from Emory stem cell expert Young-sup Yoon and his colleagues.

Young-sup Yoon, MD, PhD

The results of Yoon’s experiments, performed in mice, provide a cautionary message for researchers interested in developing cardiovascular cell therapies in humans. They suggest that careful monitoring for chromosomal abnormalities is warranted when bone marrow cells are used for cell therapies. Chromosomal abnormalities, which lead to tumor formation, may be introduced during the time when the cells are grown outside the body, the authors suggest.

Yoon and his colleagues were using mesenchymal stem cells derived from bone marrow to treat heart attack and diabetic neuropathy in mouse models. These are cells that have partially differentiated but still have the capacity to develop into different cell types, such as stromal cells, which support blood development, as well as bone and fat. If you are exploring ways to support nerve health, you may consider neuropathy supplements. Here’s what happened (from the paper’s abstract):

During the follow-up at 4 to 8 weeks after cell transplantation, growing tumors were observed in 30% of hearts in the MI [heart attack] model, and in 46% of hindlimbs in the diabetic neuropathy model.

Importantly, these were not embryonic stem cells or an emerging alternative, induced pluripotent stem cells (iPS cells). Researchers working with iPS cells have shown that the process of reprogramming them can also be imperfect.

Double asterix marks a tumor that appeared in a mouse’s heart after mesenchymal stem cell transplantation

Although the authors note that the chromosomal abnormalities they observed are usually more common in mouse cells than in human cells, Yoon says whether the effects will also be seen with human cells is still an open question. Looking ahead, using cells that have been grown in culture dishes for only a short time or not at all may be advisable, he says.

“At present, only careful karyotyping [examining and counting cells’ chromosomes] before cell transplantation would be a preventive measure,” he adds.

Posted on by Quinn Eastman in Heart Leave a comment

China-U.S. health care forum highlights similarities, challenges, solutions

The recent Westlake Forum III at Emory brought more than 250 leaders from Chinese and U.S. academic and government institutions together to examine and compare health care reform in the two countries, focusing on cost, quality, and access to care.

“This was an incredible human partnership, bringing together two countries with very different governments and cultures, recognizing our common problems and desires for improved health of all our citizens, working together on difficult issues and exploring workable solutions,” said Jeff Koplan, director of the Emory Global Health Institute.

The third Westlake Forum was the first to be held in the United States. It was co-hosted by the Emory Global Health Institute, Zhejiang University School of Medicine, and the China Medical Board.

Shanlian Hu, William Roper, William Hsaio, Jeffrey Koplan, Kenneth Thorpe

“Now China and the US are facing the same challenge: to push healthcare reform forward. Our two countries need to share knowledge and experiences with each other, and to learn from each other,” says Yu Hai, MD, PhD, director of China Medical Board Programs, Zhejiang University School of Medicine.

Howard Koh, assistant secretary for health, U.S. Department of Health and Human Services, presented an overview of U.S. health care reform.

Shanlian Hu, a professor at Fudan University, described China’s health care reform priorities: expanded coverage, equal access, improved benefits, improved care delivery systems and containment of soaring medical costs. These are remarkably similar to priorities of the recent U.S. Affordable Care Act.

In China, the government is committed to health care as a public good, with the goal of complete coverage by 2020. Although 90 percent of citizens are currently covered, cost and accessibility varies considerably. Hospital stays are longer than in the United States, medical training is less rigorous, and access to high-quality care is limited. As in the U.S., China’s public hospitals and providers struggle with the economic and quality issues generated by a “fee-for-service” reimbursement mechanism.

Participants worked on developing concrete collaborations such as joint research, educational exchanges or partnerships.

Yet health care costs in China are only 5.13 percent of the country’s GDP, compared to 17 percent in the U.S.

William Roper, dean of the University of North Carolina School of Medicine and CEO of the UNC Health System, said health care in the United States is a “paradox of excess and deprivation,” and Americans need to rethink their long-held assumptions.

Americans believe they have the best health care system in the world, yet we spend more on medical care than any other country, we are the only rich democracy in which a substantial portion of citizens lack care, nurses are in short supply, quality and safety are not as high as they should be, and incentives for physicians are skewed toward specialization and expensive technical procedures, Roper said.

Harvard Professor William Hsiao noted that China has made significant progress in health care reform over the past seven years. In 2003, 75 percent of Chinese citizens were uninsured, whereas today China offers coverage on some level to 90 percent, with out-of-pocket payments continuing to decline. Problems persist in lack of well-trained physicians and equipment, distorted prices, and profit motives of public hospitals and officials.

Ken Thorpe, from Emory’s Rollins School of Public Health, outlined the newly passed U.S. health reform law, which aims to expand and improve coverage and access to quality care and control rising costs. Many of these improvements would likely be paid through Medicare reductions and increased taxes on higher income households, he said.


 

 

 

 

 

Posted on by admin in Uncategorized Leave a comment

Indispensable cilia

Cilia are tiny hair-like structures on the outside of cells. Your memory of cilia may extend back to biology class, when you saw a picture of a paramecium or lung tissues, where cilia keep surfaces free of dirt and mucus.

Ciliated cells in the human oviduct

In the last few years, scientists have been learning more about cilia’s many roles in the body. Nearly all mammalian cells have cilia, and they are thought to act more like antennae, sending and receiving signals. Defects in cilia have been connected to lung, heart, kidney and eye diseases. Accordingly, Emory’s 15th BCMB training grant symposium focuses on cilia, beginning Thursday evening with a keynote talk by Susan Dutcher from Washington University, St. Louis and extending all day Friday.

At Emory, cell biologist Winfield Sale’s laboratory uses the model system of the alga Chlamydomonas to study dynein, a molecular motor that drives the functions of cilia. In addition, geneticist Tamara Caspary’s laboratory is studying how defects in cilia can lead to altered embryonic development. Ping Chen’s group has been examining cilia in the context of inner ear development.

This week’s program is sponsored by Emory’s graduate program in Biochemistry, Cell and Developmental Biology, the Departments of Cell Biology, Biochemistry, Pharmacology, Biology, Microbiology and Immunology, Physics, the Graduate Division of Biological and Biomedical Sciences and the Woodruff Health Sciences Center.

Posted on by Quinn Eastman in Uncategorized Leave a comment

A healthy discussion on American medical innovation

Kenneth Thorpe, PhD

Researchers and medical experts will be meeting Wednesday morning, Jan. 12 in Washington, DC, at a symposium on “Medical Innovation at the Crossroads: Choosing the Path Ahead.” Emory University’s Kenneth Thorpe, PhD, chair of the Department of Health Policy & Management, Rollins School of Public Health, and other health care experts, commentators and journalists, will discuss the most effective federal policy strategies for U.S. medical innovation aimed at job creation, economic recovery and health security.

The symposium is sponsored by the Council for American Medical Innovation.

For more information, view the council’s recent video on medical innovation.

Not long ago, polio, a crippling and dreaded disease, seemed unstoppable. But thanks to innovative medical research, the disease met its match in a vaccine developed in the early 1950s by American scientists. Today America and the world still face diseases that cripple and kill.  But with ongoing innovations in medicine and science, diseases such as diabetes and HIV/AIDs may one day meet their match, too.

On a related note, Thorpe, who regularly blogs for the Huffington Post, has written a new article, “Medical Advancements: Who Is Leading the World?”

Posted on by admin in Uncategorized 1 Comment

Internationally Recognized Violinist Raises Money for Alzheimer’s Research

Virtuoso Robert McDuffie Performs at the Schwartz Center November 19

On November 19, world famous virtuoso Robert McDuffie will dedicate the Atlanta premiere performance of Philip Glass’ “The American Four Seasons” to the Emory Alzheimer’s Disease Research Center (ADRC) and to his late father-in-law, Mack Taylor, who was a talented musician and business leader in the Atlanta community.

The event,  “A Family Affair” Dinner and Concert at Emory University, will honor Dr. Allan Levey, Director of the Emory ADRC and chair of the Neurology Department, and Dr. Stuart Zola, Associate Director of the ADRC and director of the Yerkes National Primate Research Center. Dinner guests will gather at the Carlos Museum and proceed to the Schwartz Center for Performing Arts for the concert featuring McDuffie.

The Taylor family, including Gretchen and Andrew Taylor, Camille and Robert McDuffie and Mary Rose Taylor, are serving as chairs of this inaugural event to acknowledge Alzheimer’s toll on the entire family.

Honorary Chairs Stuart Zola and Allan Levey, Directors of Emory ADRC

“I’m incredibly honored to dedicate my performance to Dr. Levey and his team of scientists at Emory’s Alzheimer’s Disease Research Center,” says McDuffie. “For 15 years, they took great care of my wonderful father-in-law Mack Taylor, who suffered from this dreadful disease.”

Alzheimer’s disease, the most common form of dementia among older adults, affects parts of the brain that control thinking, remembering and making decisions.

The incidence of Alzheimer’s is growing at an alarming rate. According to the CDC, it recently surpassed diabetes as the 6th leading cause of death among American adults. Funds raised will go toward education and collaboration so that others may learn and benefit from the work of Emory’s ADRC.

“Since millions of baby boomers are entering late adulthood, we expect the number of patients with Alzheimer’s disease to increase drastically over the next several decades,” says Levey. “We have an opportunity to build on the momentum of much exciting research progress in early identification of disease and development of many new treatment strategies that offer promise to slow its progression and lead to prevention.”

Emory’s ADRC is a National Institute on Aging funded center focused on clinical trials and research for Alzheimer’s disease. The only comprehensive program in Georgia and one of only 32 nationwide, the Emory ADRC is seeking cures through basic laboratory research, bringing new diagnostic methods and treatments into the clinic, and providing patients and their families with state-of-the-art care and access to cutting-edge advances.

The $150 tickets ($100 is tax deductible) are available at www.alumni.emory.edu/ADRC-AFamilyAffair or by calling 404-727-5713.

Posted on by admin in Uncategorized Leave a comment

Cholera in the time of disaster

Alex Larsen couldn’t make it to the 2010 International Association of National Public Health Institutes (IANPHI) annual meeting. That’s because Larsen, Haiti’s minister of health, was attending to an outbreak of cholera in this impoverished republic.

Vibrio cholerae bacteria

Larsen was scheduled to speak on NPHIs’ role in disaster preparedness and response. Instead, Scott Dowell, director of the CDC’s division of global disease detection and emergency response, updated attendees about goings-on in Haiti since the massive January 12 earthquake and the recent outbreak of cholera.

The first two weeks after the tremblor and its immediate aftershocks, human and monetary resources were spent on search and rescue, including emergency trauma care, orthopedic surgery and amputations, says Dowell.

The number killed now stands at 200,000. The number displaced: 1.3 million. In addition to an initial lack of safe drinking water, hunger and poor sanitation, anecdotal accounts of diphtheria and tetanus outbreaks circulated. The headquarters housing the ministry of public health was itself devastated when it collapsed, killing most of the minister’s staff who had remained inside.

Since the earthquake, Dowell says the water supply has slowly improved with long-term sources coming on line. Efforts to better separate sewage and water are coming to fruition, too.

As far as the cholera outbreak is concerned, this chapter of Haiti’s public health challenges is just beginning thanks in part to Haiti having never before experienced a known cholera epidemic, says Dowell. That is, its population is most likely immunologically naïve to cholera, making people vulnerable to the bacteria’s devastating ways: severe diarrhea, vomiting, and abdominal pain culminating in overwhelming dehydration and even death.

Despite its troubles, Dowell says there’s long-term hope for Haiti. As found in other countries affected by cholera, an aggressive program to provide clean water and keep sewage and water separate, can eventually squelch the bacteria’s rampage—and in the meantime prevent other diseases from taking hold.

Posted on by admin in Uncategorized Leave a comment

Initial Results of Heart Valve Study Encouraging

 

Emory heart patient, Glenrose Gay of Vidalia was the first person in GA to receive a new aortic valve via catheter. Pictured here in 2007 with Emory cardiologists, Drs. Peter Block (left) and Vasilis Babaliaros.

Since October 2007, Emory University Hospital has been one of approximately 20 hospitals nationwide, and the only site in Georgia, studying a new non-surgical treatment option for patients with failing aortic valves. The life threatening heart condition,aortic stenosis, affects tens of thousands of Americans each year when the aortic valve tightens or narrows, preventing blood from flowing through normally.

As part of the Phase II clinical trial, researchers have been performing transcatheter aortic valve implantation (TAVI) comparing this procedure with traditional, open-heart surgery or medical therapy in high-risk patients with aortic stenosis.

During the TAVI procedure, doctors create a small incision in the groin or chest wall and then feed the new valve, mounted on a wire mesh on a catheter, and place it where the new valve is needed. This offers a non-invasive way for doctors to treat patients who are too ill or frail to endure the traditional open-heart surgical approach.

The study, published Wednesday in The New England Journal of Medicine (NEJM) followed 358 patients who received either catheter-delivered valves or standard non-surgical treatment.

The findings showed that patients who had replacement heart valves delivered by catheter were more likely to survive a year than patients who were treated without replacing their original valves. According to the authors, catheter-delivered valves “should be the new standard of care” for patients who are not able to undergo surgery.

“These results show great promise for patients with severe aortic stenosis and help us make a giant step forward in our battle against this common disease,” says Peter Block, MD, professor of medicine, Emory School of Medicine and principal investigator of the study at Emory. “They are especially important since the number of people with failing valves is expected to greatly increase as baby boomers continue to age.”

Aortic valve stenosis often occurs with age, most commonly among elderly patients over 70 years of age, but can surface earlier in life in those with rheumatic heart disease or congenital abnormalities of the valve.

Approximately 90 patients have received new valves at Emory since the clinical trial started in 2007. Researchers hope to receive FDA approval in late 2011.

Posted on by admin in Uncategorized Leave a comment

First of its kind neurosurgery boot camp held at Emory

Emory’s Department of Neurosurgery recently hosted a two-day boot camp for first-year neurosurgery residents. The unique event was part of a new national course launched by the Society of Neurological Surgeons (SNS) in Atlanta and five other cities including Boston, Portland and Chicago.

The course focused on fundamental skills, patient safety, professionalism and communications. Day one was structured in a traditional lecture format, while day two placed participants in simulated operating room environments and neurosurgical procedures.

A first-year neurosurgery resident participates in the nation's first series of neurosurgery boot camps.

“This boot camp concept is the first of its kind in medicine providing interns with a strong foundation to learn basic concepts and procedures and helping to ultimately reduce the number of errors among training residents,” says Costas Hadjipanayis, MD, PhD, assistant professor of neurosurgery at Emory School of Medicine and chief of neurosurgery service at Emory University Hospital Midtown.

More than 90 percent of all incoming neurosurgery residents in the United States participated in the training at one of the sites. Emory neurosurgical faculty, fellows, and residents led intensive and interactive exercises oriented to fundamental bedside procedural and operative skills.

The exercises were designed to allow residents to familiarize themselves with the basics in an educational and risk-free environment. Skills relevant to all first-year residents were covered, such as line placement and suturing, as well as specific neurosurgical skills like drilling and performing a craniotomy.

According to Hadjipanayis, one of the Emory organizers and course directors, the group of 37 interns participating in the Atlanta training was the largest number nationwide. They were from universities across the region ranging from Virginia to Puerto Rico.

“This was definitely a great start to a course we will cultivate and enhance from year to year,” says Hadjipanayis. “Our goal is for continuous evaluation and improvement.”

Click here to view a CNN news story filmed at the Emory boot camp by CNN medical correspondent and Emory neurosurgeon, Sanjay Gupta, MD.

Posted on by admin in Uncategorized Leave a comment

Little eyes – big research

Having a newborn and managing all that comes with caring for that new little one is a big job. Add to that frequent trips to the ophthalmologist following a cataract surgery—yes, cataract surgery on a baby—and you might have highly stressed parents. But the parents of little James and slightly older M.J. seem unfazed by all the medical appointments and additional duties that go along with caring for their young sons.

M.J. Burkett and James Weeks became patients in the IATS trial, which has treated 114 babies across the United States.

Both the boys, like 300 babies each year in the United States, were born with a cataract in one eye. In an infant, if the affected eye isn’t surgically addressed within the first few months of life, that eye will not develop properly and vision can be permanently lost. These boys and their parents and 112 other young patients and their families have participated in the Infant Aphakia Treatment Study (IATS), a nationwide, multi-center clinical trial based at the Emory Eye Center. The 10-year study will evaluate whether replacing that lost lens with a contact lens or an intraocular lens (IOL) is preferable.

Adults typically get an IOL implant following cataract surgery. In the past, standard treatment was a contact lens for these babies. IATS randomized children into two groups: those who received IOL implants and those who received contact lenses. Those with IOLs also received glasses for residual vision correction. And both groups had daily patching of the unaffected eye to make sure that the newly corrected eye could become strong.

A team of professionals from Emory and beyond came together to provide the many layers of data necessary for the study. They included experts from the Rollins School of Public Health and the Department of Epidemiology and Data Coordinating Center in the Department of Biostatistics and Bioinformatics, as well as a visual acuity tester from the University of Alabama, Birmingham, who traveled to all sites to check these children.

For more information about IATS, read the feature article “One Big Question: Ten Diligent Years” in Emory Eye magazine’s summer 2010 issue.

Posted on by admin in Uncategorized Leave a comment